Anti-GUC2B/ GUCA2B/ GCAP-II functional antibody

Anti-GUC2B/ GUCA2B/ GCAP-II functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to GUCA2B/GUCA2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0250-Ab-1/ GM-Tg-hg-SE0250-Ab-2Anti-Human GUCA2B monoclonal antibodyHuman
GM-Tg-rg-SE0250-Ab-1/ GM-Tg-rg-SE0250-Ab-2Anti-Rat GUCA2B monoclonal antibodyRat
GM-Tg-mg-SE0250-Ab-1/ GM-Tg-mg-SE0250-Ab-2Anti-Mouse GUCA2B monoclonal antibodyMouse
GM-Tg-cynog-SE0250-Ab-1/ GM-Tg-cynog-SE0250-Ab-2Anti-Cynomolgus/ Rhesus macaque GUCA2B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0250-Ab-1/ GM-Tg-felg-SE0250-Ab-2Anti-Feline GUCA2B monoclonal antibodyFeline
GM-Tg-cang-SE0250-Ab-1/ GM-Tg-cang-SE0250-Ab-2Anti-Canine GUCA2B monoclonal antibodyCanine
GM-Tg-bovg-SE0250-Ab-1/ GM-Tg-bovg-SE0250-Ab-2Anti-Bovine GUCA2B monoclonal antibodyBovine
GM-Tg-equg-SE0250-Ab-1/ GM-Tg-equg-SE0250-Ab-2Anti-Equine GUCA2B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0250-Ab-1/ GM-Tg-hg-SE0250-Ab-2; GM-Tg-rg-SE0250-Ab-1/ GM-Tg-rg-SE0250-Ab-2;
GM-Tg-mg-SE0250-Ab-1/ GM-Tg-mg-SE0250-Ab-2; GM-Tg-cynog-SE0250-Ab-1/ GM-Tg-cynog-SE0250-Ab-2;
GM-Tg-felg-SE0250-Ab-1/ GM-Tg-felg-SE0250-Ab-2; GM-Tg-cang-SE0250-Ab-1/ GM-Tg-cang-SE0250-Ab-2;
GM-Tg-bovg-SE0250-Ab-1/ GM-Tg-bovg-SE0250-Ab-2; GM-Tg-equg-SE0250-Ab-1/ GM-Tg-equg-SE0250-Ab-2
Products NameAnti-GUCA2B monoclonal antibody
Formatmab
Target NameGUCA2B
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GUCA2B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0250-Ag-1Recombinant multi-species GUC2B/ GUCA2B/ GCAP-II protein
    ORF Viral VectorpGMLP005002human GUCA2B Lentivirus plasmid
    ORF Viral VectorvGMLP005002human GUCA2B Lentivirus particle
    ORF Viral VectorpGMLPm000973mouse Guca2b Lentivirus plasmid
    ORF Viral VectorvGMLPm000973mouse Guca2b Lentivirus particle


    Target information

    Target IDGM-SE0250
    Target NameGUCA2B
    Gene ID2981,14916,64055,699525,100684829,101092381,515664,100067585
    Gene Symbol and SynonymsGCAP-II,Gcap2,GUCA2B,UGN
    Uniprot AccessionQ16661,P70668
    Uniprot Entry NameGUC2B_HUMAN,GUC2B_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseMalignant neoplasm of bladder
    Gene EnsemblENSG00000044012
    Target ClassificationN/A

    The target: GUCA2B, gene name: GUCA2B, also named as GCAP-II, UGN. This gene encodes a preproprotein that is proteolytically processed to generate multiple protein products, including uroguanylin, a member of the guanylin family of peptides and an endogenous ligand of the guanylate cyclase-C receptor. Binding of this peptide to its cognate receptor stimulates an increase in cyclic GMP and may regulate salt and water homeostasis in the intestine and kidneys. [provided by RefSeq, Nov 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.